Literature DB >> 18679393

The rationale for sentinel-node biopsy in primary melanoma.

Donald L Morton1, Alistair J Cochran, John F Thompson.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18679393      PMCID： PMC2574663          DOI： 10.1038/ncponc1205

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN： 1743-4254


× No keyword cloud information.
  10 in total

1.  Sentinel-node biopsy in melanoma.

Authors:  Spyros Retsas
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

2.  Why perform sentinel-lymph-node biopsy in patients with melanoma?

Authors:  Steven A Rosenberg
Journal:  Nat Clin Pract Oncol       Date:  2008-01

Review 3.  Prognostic false-positivity of the sentinel node in melanoma.

Authors:  J Meirion Thomas
Journal:  Nat Clin Pract Oncol       Date:  2008-01

4.  Can completion lymph node dissection be avoided for a positive sentinel node in melanoma?

Authors:  Donald L Morton; Randall P Scheri; Charles M Balch
Journal:  Ann Surg Oncol       Date:  2007-06-17       Impact factor: 5.344

5.  Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.

Authors:  Donald L Morton; Alistair J Cochran; John F Thompson; Robert Elashoff; Richard Essner; Edwin C Glass; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harald J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; He-jing Wang
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

6.  Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma.

Authors:  Emma C Starritt; Roger F Uren; Richard A Scolyer; Michael J Quinn; John F Thompson
Journal:  Ann Surg Oncol       Date:  2004-12-27       Impact factor: 5.344

7.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Authors:  C M Balch; S J Soong; J E Gershenwald; J F Thompson; D S Reintgen; N Cascinelli; M Urist; K M McMasters; M I Ross; J M Kirkwood; M B Atkins; J A Thompson; D G Coit; D Byrd; R Desmond; Y Zhang; P Y Liu; G H Lyman; A Morabito
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

8.  Sentinel-node biopsy or nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Robert Elashoff; Richard Essner; Omgo E Nieweg; Daniel F Roses; Harald J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; Edwin C Glass; He-Jing Wang
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

9.  Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.

Authors:  Randall P Scheri; Richard Essner; Roderick R Turner; Xing Ye; Donald L Morton
Journal:  Ann Surg Oncol       Date:  2007-07-18       Impact factor: 5.344

10.  Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.

Authors:  Michael S Sabel; Kent A Griffith; Alisha Arora; Josef Shargorodsky; Dan G Blazer; Riley Rees; Sandra L Wong; Vincent M Cimmino; Alfred E Chang
Journal:  Surgery       Date:  2007-06       Impact factor: 3.982
  10 in total
  15 in total

Review 1.  Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.

Authors:  Athanassios Kyrgidis; Thrasivoulos Tzellos; Simone Mocellin; Zoe Apalla; Aimilios Lallas; Pierluigi Pilati; Alexander Stratigos
Journal:  Cochrane Database Syst Rev       Date:  2015-05-16

2.  Management of conjunctival malignant melanoma: a review and update.

Authors:  James R Wong; Afshan A Nanji; Anat Galor; Carol L Karp
Journal:  Expert Rev Ophthalmol       Date:  2014-06

3.  [Skin cancer in organ transplant patients. Epidemiology and management].

Authors:  U Leiter; C Garbe
Journal:  Hautarzt       Date:  2010-03       Impact factor: 0.751

4.  Local recurrence and assessment of sentinel lymph node biopsy in deep soft tissue leiomyosarcoma of the extremities.

Authors:  Michael J Lamyman; Hank P Giele; Paul Critchley; Duncan Whitwell; Max Gibbons; Nick A Athanasou
Journal:  Clin Sarcoma Res       Date:  2011-08-01

Review 5.  Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

Authors:  Dale Han; Daniel C Thomas; Jonathan S Zager; Barbara Pockaj; Richard L White; Stanley Pl Leong
Journal:  World J Clin Oncol       Date:  2016-04-10

Review 6.  Implementing sentinel lymph node biopsy programs in developing countries: challenges and opportunities.

Authors:  Mohammed Keshtgar; John J Zaknun; Durre Sabih; Graciela Lago; Charles E Cox; Stanley P L Leong; Giuliano Mariani
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

Review 7.  Importance of tumor load in the sentinel node in melanoma: clinical dilemmas.

Authors:  Alexander C J van Akkooi; Cornelis Verhoef; Alexander M M Eggermont
Journal:  Nat Rev Clin Oncol       Date:  2010-06-22       Impact factor: 66.675

8.  Desmoplastic melanoma: is there a role for sentinel lymph node biopsy?

Authors:  Dale Han; Jonathan S Zager; Daohai Yu; Xiuhua Zhao; Brooke Walls; Suroosh S Marzban; Nikhil G Rao; Vernon K Sondak; Jane L Messina
Journal:  Ann Surg Oncol       Date:  2013-02-07       Impact factor: 5.344

9.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

10.  Thick melanoma: prognostic value of positive sentinel nodes.

Authors:  Lenka Vermeeren; Fred W C van der Ent; Prapto S H Sastrowijoto; Karel W E Hulsewé
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.